Andrew Yule & Company Limited

NSE:ANDREWYU.NS

31.7 (INR) • At close October 25, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 765.726859.904868.874585.377798.2061,194.4571,162.272565.487592.5931,054.6591,240.068456.279562.1961,064.0911,309.834347.644408.337857.4711,094.37610.62665.57821.605986.318576.3911,092.618846.203865.165355.341
Cost of Revenue 1,009.05353.556210.209101.6416.673600.541178.81853.292423.923355.127307.798-100.37433.109373.05194.528-52.609359.004257.015216.01999.097502.554258.358181.60849.592568.401299.954232.64-3.444
Gross Profit -243.324506.348658.665483.777381.533593.916983.454512.195168.67699.532932.27556.649129.087691.0411,115.306400.25349.333600.456878.351511.523163.016563.247804.71526.799524.217546.249632.525358.785
Gross Profit Ratio -0.3180.5890.7580.8260.4780.4970.8460.9060.2850.6630.7521.220.230.6490.8511.1510.1210.70.8030.8380.2450.6860.8160.9140.480.6460.7311.01
Reseach & Development Expenses 00003.79600000000000000000000000
General & Administrative Expenses 0000193.61800000000000000000000000
Selling & Marketing Expenses 00001.85500000000000000000000000
SG&A 130.087190.587196.061523.808195.473141.837252.007537.945890.461478.646582.86600000000000000000
Other Expenses 94.22116.65175.784100.072102.53787.277102.84424.869-400.02217.372211.5929.898-243.611125.083135.71923.706-188.258112.73392.07230.047-145.58995.791156.95817.633634.702454.204464.638358.421
Operating Expenses 130.087733.249794.984710.838565.441550.263781.81701.443-602.121749.287828.837627.979441.562710.917776.613479.919411.248651.516805.234605.458297.169640.895734.852641.551634.702454.204464.638358.421
Operating Income -373.411-110.249-60.535-227.061-81.372130.93304.489-189.2484.517-49.755103.433-71.33-312.475-19.876338.693-79.666-361.915-51.0673.117-93.935-134.153-77.64869.858-114.752-110.48592.045167.8870.364
Operating Income Ratio -0.488-0.128-0.07-0.388-0.1020.110.262-0.3350.008-0.0470.083-0.156-0.556-0.0190.259-0.229-0.886-0.060.067-0.154-0.202-0.0950.071-0.199-0.1010.1090.1940.001
Total Other Income Expenses Net 46.643-43.117-31.756151.963-28.633-27.592-21.19287.979-53.145-16.77380.84110.0326.529107.734118.577-11.9651.96388.60770.44310.169105.2782.793136.7655.862115.978-40.228-40.487-45.421
Income Before Tax -326.768-153.366-92.291-159.512-110.005103.338283.297-186.907-57.85-55.489285.379-61.298-305.94687.858457.27-91.626-309.95237.547143.56-83.766-28.8835.145206.623-108.895.49351.817127.4-45.057
Income Before Tax Ratio -0.427-0.178-0.106-0.272-0.1380.0870.244-0.331-0.098-0.0530.23-0.134-0.5440.0830.349-0.264-0.7590.0440.131-0.137-0.0430.0060.209-0.1890.0050.0610.147-0.127
Income Tax Expense -54.936-21.112-19.668100.072-15.41556.52836.96317.967120.806217.372211.585-29.136-64.93988.143150.777-17.907-10.581113.2033.244-3.244130.595.791227.045-52.454-104.676000
Net Income -222.141-124.78-52.723-75.098-58.60569.896209.524-94.367-168.915-66.528184.28-2.265-165.668124.798442.212-50.012-303.41737.07672.66-23.168-46.7585.145136.536-38.803110.16951.817127.4-45.057
Net Income Ratio -0.29-0.145-0.061-0.128-0.0730.0590.18-0.167-0.285-0.0630.149-0.005-0.2950.1170.338-0.144-0.7430.0430.066-0.038-0.070.0060.138-0.0670.1010.0610.147-0.127
EPS -0.45-0.26-0.11-0.15-0.120.140.43-0.19-0.35-0.140.38-0.005-0.350.260.9-0.1-0.650.080.15-0.05-0.0910.010.28-0.080.340.160.39-0.14
EPS Diluted -0.45-0.26-0.11-0.15-0.120.140.43-0.19-0.34-0.140.38-0.005-0.350.260.9-0.1-0.650.080.15-0.05-0.0910.010.28-0.080.340.160.39-0.14
EBITDA -351.444-96.351-45.906-107.952-61.654145.34322.153-151.697755.665180.474331.14-24.904-292.078119.582490.528-39.683-285.47578.355181.788-47.088-2.99433.945245.943-81.156-96.343103.746179.13511.49
EBITDA Ratio -0.459-0.112-0.053-0.184-0.0770.1220.277-0.2681.2750.1710.267-0.055-0.520.1120.374-0.114-0.6990.0910.166-0.077-0.0040.0410.249-0.141-0.0880.1230.2070.032